Tomarce, Baby Boy .
HRN: 22-47-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2023
CEFOTAXIME 500MG (VIAL)
01/14/2023
01/21/2023
IV
175mg
Q12
Neonatal Sepsis; Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes